Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT06256211

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06256211
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06256211. Randomized; single masking; primary purpose treatment. Start 2024-03-01 (anticipated); primary completion 2024-11-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates
Condition
Patent Ductus Arteriosus
Intervention (Drug)
Paracetamol
Lead sponsor
Soha mahmoud Hussien mahdy (class: other)
Collaborator
Assiut University (class: other)

Record details

Record id
cardio:ct-nct06256211
Content hash
69f83d724859d567c1ef343864617d638d6000d045988b2f927ec7276cf85fad